ANEW MEDICAL, INC. (LEAS)
- Previous Close
0.0002 - Open
0.0002 - Bid --
- Ask --
- Day's Range
0.0002 - 0.0002 - 52 Week Range
0.0001 - 0.0098 - Volume
200,000 - Avg. Volume
5,843,113 - Market Cap (intraday)
1M - Beta (5Y Monthly) 0.27
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
ANEW MEDICAL, INC. focuses on developing biologic medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. The company is based in Omaha, Nebraska.
www.anewmeds.com1
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: LEAS
Performance Overview: LEAS
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LEAS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LEAS
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
16.00
Enterprise Value/EBITDA
-1.07
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-684.87k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
2.14k
Total Debt/Equity (mrq)
193.00%
Levered Free Cash Flow (ttm)
--
Company Insights: LEAS
LEAS does not have Company Insights